Scopus BioPharma Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Scopus BioPharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q2 2023.
  • Scopus BioPharma Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 39.7M shares, a 88.4% increase year-over-year.
  • Scopus BioPharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 21.1M shares, a 22.3% increase from 2021.
  • Scopus BioPharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 17.3M shares, a 29.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 39.7M +18.6M +88.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 30.4M +9.28M +44% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 21.1M +3.84M +22.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-14
Q3 2022 21.1M +3.95M +23% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 21.1M +4.9M +30.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 21.1M +5.76M +37.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 17.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 17.1M +3.16M +22.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 16.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 15.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-19
Q3 2020 14M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.